Companies

Armata Pharmaceuticals, Inc. (ARMP) SEC filings

CIK 0000921114 · Biological Products, (No Diagnostic Substances) (SIC 2836) · NYSE · incorporated in WA · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Net income (USD)-36.9 M-23.2 M
Diluted EPS (USD/shares)-4.8-1.91-1.08

Latest filings

FiledFormDescriptionPeriod
2026-09-238-KFORM 8-K items 8.01,9.012026-09-23
2026-09-148-KFORM 8-K items 7.01,9.012026-09-14
2026-08-1210-Q10-Q2026-06-30
2026-08-128-K8-K items 2.02,9.012026-08-12
2026-07-208-KFORM 8-K items 7.01,9.012026-07-20
2026-07-208-KFORM 8-K items 5.02,9.012026-07-17
2026-07-144OWNERSHIP DOCUMENT2026-07-10
2026-07-138-KFORM 8-K items 7.01,9.012026-07-13
2026-07-13S-8FORM S-8
2026-06-248-K/A8-K/A items 5.022026-04-24
2026-06-238-KFORM 8-K items 8.01,9.012026-06-23
2026-06-168-KFORM 8-K items 5.072026-06-11
2026-05-13SCHEDULE 13D/ASCHEDULE 13D/A
2026-05-1310-Q10-Q2026-03-31
2026-05-138-K8-K items 1.01,2.02,2.03,7.01,9.012026-05-12
2026-05-078-KFORM 8-K items 7.01,9.012026-05-07
2026-04-284OWNERSHIP DOCUMENT2026-04-24
2026-04-283OWNERSHIP DOCUMENT2026-04-24
2026-04-27ARSARS2025-12-31
2026-04-27DEF 14ADEF 14A2026-06-11
2026-04-278-KFORM 8-K items 5.02,7.01,9.012026-04-24
2026-04-028-KFORM 8-K items 8.012026-04-02
2026-03-2510-K10-K2025-12-31
2026-03-258-K8-K items 2.02,9.012026-03-25
2026-03-198-KFORM 8-K items 7.01,9.012026-03-19

Forms on file (last 1,000): 8-K 282, 4 216, 10-Q 56, 3 40, CORRESP 37, UPLOAD 33, DEF 14A 24, SC 13D/A 23. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ARMP (0.002 USD), /gw/filings/filings?ticker=ARMP&form=8-K, /gw/filings/facts?ticker=ARMP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange